Watch Amazon, Dexcom, Corteva, and Coinbase
Amazon shares rose after Q2 results, with revenue up 20% Y/Y to $200.6B and AWS revenue up 36.7% to $42.2B. Dexcom hit a 52-week high after Q2 results and a 2026 revenue outlook of $5.18B to $5.25B. Corteva fell after Q2 revenue of $6.38B, but raised guidance, with operating EBITDA above $4.3B. Coinbase dropped after Q2 GAAP EPS of -$1.36 and weaker Q3 subscription and services revenue.
How this was made
The 30-second read
Why it matters
The text provides specific Q2 results and at least one forward guidance range (DXCM) plus COIN’s EPS and Q3 revenue cap, which can inform near-term positioning and volatility expectations.
Market read
Traders can use the provided guidance figures and earnings reaction direction to manage momentum and event-volatility risk across cloud, medtech, agri-chem, and crypto-exposed equities.
What to watch
For COIN, the key swing factor is whether crypto trading volume growth (10.3% vs 8.6% in Q1) offsets weaker subscription/services revenue; for AMZN and DXCM, the durability of AI-driven margins and device demand is not stress-tested with churn, utilization, or competitive metrics.
Background
This is a multi-name watchlist-style recap of recent earnings reactions and guidance ranges across AMZN, DXCM, CTVA, and COIN.
Ticker impact
Amazon shares gained 17% last week after Q2 revenue grew 20% Y/Y to $200.6B, with AWS revenue up 36.7% Y/Y.
Bias modestly positive for follow-through, but magnitude likely limited since this is framed as a recap of the already-reported results.
The article provides specific Q2 and AWS growth figures, but it does not indicate a new post-release development beyond the results reaction.
Dexcom traded to a 52-week high after Q2 results, with 2026 revenue forecast of $5.18B to $5.25B.
Near-term upside bias as traders reprice the forward revenue outlook.
The piece includes a concrete revenue guidance range tied to the Q2 results reaction, but it does not specify whether the guidance is newly released today versus already known.
Corteva fell about 12% after reporting Q2 revenue of $6.38B, down 2.4% Y/Y, despite increased full-year guidance.
Choppy, with direction dependent on how the market interprets the guidance increase versus the revenue miss.
The article gives directionally conflicting signals but lacks the actual guidance numbers, limiting conviction on the market’s likely next move.
Coinbase dropped 10.59% after earnings, with Q2 GAAP EPS of -$1.36 and Q3 subscription and services revenue up to $580M.
Downside pressure likely persists if traders extrapolate weaker transaction volumes into Q3.
The article provides specific EPS and revenue guidance figures and links them to a crypto slump, which is actionable for positioning.
Market effects
AI-driven demand supports cloud software sentiment (AMZN/AWS read-through), while medical device and crypto trading volumes highlight sector-specific growth and risk sensitivities.
Primarily US-listed large-cap and growth names; limited direct regional spillover implied.
Crypto slump linkage suggests broader risk-off in digital-asset-linked equities, but no explicit global macro trigger is cited.
Counterpoint
The article may over-weight the immediate post-earnings price reaction; without the exact guidance numbers for CTVA and without consensus comparisons, the market’s next move could be less directional than implied.
Key entities
- companyAmazon
Q2 revenue growth and AWS growth cited as the driver of a 17% weekly stock gain.
- companyDexcom
Q2 results and a 2026 revenue forecast range cited alongside a move to a 52-week high.
- companyCorteva
Q2 revenue decline cited alongside increased full-year guidance, despite a ~12% drop.
- companyCoinbase Global
Earnings-driven decline cited with GAAP EPS and a Q3 subscription/services revenue cap.
